FASN and posterior cortical atrophy: Our in vitro results also show the potential anticancer action of FASN inhibition, which exhibited a strong antiproliferative effect in PCa, supporting the hypothesis that this different sensitivity might also be related to the onco-metabolic role of FASN in PCa.